Cardiovascular Device Update articles from December 2006

Cardiovascular Device Update archives from December 2006

Focusing selective therapy on cardiovascular disease.
December 1, 2006... Focusing selective therapy on cardiovascular disease By MIKE SIMONSEN CDU Contributing Writer CHICAGO — Cardiovascular disease — the leading cause of death in the U.S. and a major cause of morbidity — also...

2006 AHA conference a bit more subdued ; as well it should be.(American Hospital Assocation)(Conference news)
December 1, 2006... Commentary 2006 AHA conference a bit more subdued — as well it should be By DON LONG CDU Managing Editor CHICAGO — Associations that target specific diseases are usually optimistic. They have to be. They put...

J&J bolsters DES via $1.4B deal for Conor Medsystems.
December 1, 2006... J&J bolsters DES via $1.4B deal for Conor Medsystems By HOLLAND JOHNSON CDU Associate Managing Editor In a bid to expand its pipeline, especially giving itself an edge in the highly competitive drug-eluting stent (DES) market,...

Medtronic makes final filing for Endeavor PMA.
December 1, 2006... Medtronic makes final filing for Endeavor PMA As suggested by Johnson & Johnson's purchase of Conor Medsystems, the major players are lining up for battle in the "second-generation" drug-eluting stent (DES) wars. Another indication is the...

STENTS, stem cells, genes hottest of hot conference talk.
December 1, 2006... STENTS, stem cells, genes hottest of hot conference talk By HOLLAND JOHNSON CDU Associate Managing Editor And MARK McCARTY CDU Washington Editor WASHINGTON — The 2006 edition of the Transcatheter Cardiovascular...

One-kind-makes-all may be stem cell pathway to heart.
December 1, 2006... One-kind-makes-all may be stem cell pathway to heart By ANETTE BREINDL CDU Science Editor Several studies in recent and upcoming issues of Cell and Developmental Cell, respectively, have identified cardiac stem cells that give...

International report.
December 1, 2006... International report Initial implants in Sorin dual-chamber ICD OPTION trial A CDU Staff Report The Cardiac Rhythm Management group of Sorin Group (Milan, Italy) reported the initiation of the Optimal Antitachycardia Therapy in ICD...

Acquisitions.
December 1, 2006... Acquisitions • The FDA has approved the NexStent Carotid and Monorail Delivery System for carotid artery disease patients who are at high risk for surgery — that approval taking Boston Scientific (Natick, Massachusetts) within...

Business Developments.
December 1, 2006... Business Developments Medtronic to spin its AED business In a move that may alter the dynamics of the automated external defibrillator (AED) market, Medtronic (Minneapolis) has unveiled a plan to send its 1998 acquisition,...

Agreements.
December 1, 2006... Agreements • Cardiac Science (Bothell, Washington) has signed an amendment to its agreement with GE Healthcare (Little Chalfont, UK) which extends the agreement's term to five years from the original three years. GE Healthcare, a...

Cleveland Clinic in new treatment for atrial fibrillation.
December 1, 2006... Cleveland Clinic in new treatment for atrial fibrillation Pulmonary vein antrum isolation (PVAI), a new treatment for atrial fibrillation (AF), has been found to produce regression in irregular heartbeats in most patients and improves heart...

Personnel File.(appointments in the medical equipment industry)
December 1, 2006... Personnel File • Robert Mitchell has been hired as executive VP and chief operating officer of AngioDynamics. (Queensbury, New York), a new position. Previously, Mitchell was president/CEO and director for Millimed Holdings....

Product Pipeline.
December 1, 2006... Product Pipeline CVRx wins IDE for pacemaker-like hypertension device If ongoing trials are successful, the device sector may one day have another innovative implantable technology, this one used to treat difficult-to-manage high blood...